Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

Prof. Benjamin Rolland give us a summary of the session, the most important messages.

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

Prof. Silvana Galderisi speaks about how big is the burden of COVID-19 on patients with schizophrenia. What are the greatest challenges for physicians and care givers?

Consequences of COVID-19 Outbreak on Mental Health

Prof. Celso Arango speaks about the lessons he learned from coronavirus health crisis in Spain. He shares the most important findings and messages of his presentation.

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

Birth Asphyxia: Is this an area of primary pevention in schizophrenia? Prof. Robin Murray speaks about the most important findings of his presentation.

Difficult to Treat Depression

Prof. Andrea Fiorillo speaks about the newest novelties on the treatment of depression.

Consequences of COVID-19 Outbreak on Mental Health

Prof. Axel Börsch-Supan speaks about the most important findings of the Survey of Health, Ageing and Retirement in Europe (SHARE).

Highlights of the EPA 2021

Prof. Peter Falkai, the newly elected President of EPA summarize the highlights of the recent congress.

Antipsychotic treatment: polypharmacy is better than monotherapy – PRO

Guidance for treatment of ADHD in adults

ADHD in adults

Functional recovery in depression: role of cognitive symptoms

Treatment of schizophrenia negative symptoms: Do we have an adequate solution?

Schizophrenia is a Myth with a Strong Genetic Component

Cybersuicide in young people: implications for suicide prevention

Identification and diagnosis of patients with TRD and Clinical pathways for patients with TRD

Clinical management of cognitive symptoms in depression